At Leucadia Pharmaceuticals, we are set to be leaders in the generic injectable market. We're investing heavily, expanding operations and scientific personnel, while also pursuing partnerships and product acquisitions. Our goal is to provide important new generic injectable products to the acute and specialty markets, and to reach communities and conditions that are under-served. Leucadia Pharmaceuticals was established in 2015 as the commercial arm of Custopharm, Inc., and is associated with Water Street Healthcare Partners.